Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Parikh

Showing results (381-390 of 399) with videos related to

Pageof 40
Sort By:
ACS Medicinal Chemistry Letters|January 19, 2019
Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group TuningMark E Schnute, Stephen E Benoit, Ingrid P Buchler, et al.
Gastroenterology|August 3, 2019
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular CarcinomaAmit G Singal, Nicole E Rich, Neil Mehta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2023
Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular CarcinomaHidenori Toyoda, Mounika Kanneganti, Jonathan Melendez-Torres, et al.
Journal of Medicinal Chemistry|January 4, 2018
Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune DiseasesMichael L Vazquez, Neelu Kaila, Joseph W Strohbach, et al.
Hepatology Communications|June 14, 2023
Thermal ablation compared to stereotactic body radiation therapy for hepatocellular carcinoma: A multicenter retrospective comparative studyAndrew M Moon, Hannah P Kim, Amit G Singal, et al.
JHEP Reports : Innovation in Hepatology|January 29, 2025
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumabMeng Wu, Claudia A M Fulgenzi, Antonio D'Alessio, et al.
Science Translational Medicine|June 22, 2022
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver diseaseNaoto Fujiwara, Naoto Kubota, Emilie Crouchet, et al.
International Journal of Cancer|September 27, 2025
Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traitsYounghun Han, Vikram R Shaw, Jinyoung Byun, et al.
Nature Communications|March 10, 2026
Discovery of an ITK and TRK kinase inhibitor for the potential topical treatment of atopic dermatitisJennifer L Duffen, Kimberly K Crouse, Lin Ji, et al.
Gastroenterology|January 21, 2019
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort StudyAmit G Singal, Nicole E Rich, Neil Mehta, et al.
Pageof 40

Showing results (381-390 of 399) with videos related to

Sort By:
Pageof 40
ACS Medicinal Chemistry Letters|January 19, 2019
Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group TuningMark E Schnute, Stephen E Benoit, Ingrid P Buchler, et al.
Gastroenterology|August 3, 2019
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular CarcinomaAmit G Singal, Nicole E Rich, Neil Mehta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2023
Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular CarcinomaHidenori Toyoda, Mounika Kanneganti, Jonathan Melendez-Torres, et al.
Journal of Medicinal Chemistry|January 4, 2018
Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune DiseasesMichael L Vazquez, Neelu Kaila, Joseph W Strohbach, et al.
Hepatology Communications|June 14, 2023
Thermal ablation compared to stereotactic body radiation therapy for hepatocellular carcinoma: A multicenter retrospective comparative studyAndrew M Moon, Hannah P Kim, Amit G Singal, et al.
JHEP Reports : Innovation in Hepatology|January 29, 2025
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumabMeng Wu, Claudia A M Fulgenzi, Antonio D'Alessio, et al.
Science Translational Medicine|June 22, 2022
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver diseaseNaoto Fujiwara, Naoto Kubota, Emilie Crouchet, et al.
International Journal of Cancer|September 27, 2025
Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traitsYounghun Han, Vikram R Shaw, Jinyoung Byun, et al.
Nature Communications|March 10, 2026
Discovery of an ITK and TRK kinase inhibitor for the potential topical treatment of atopic dermatitisJennifer L Duffen, Kimberly K Crouse, Lin Ji, et al.
Gastroenterology|January 21, 2019
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort StudyAmit G Singal, Nicole E Rich, Neil Mehta, et al.
Pageof 40